InVivoMAb anti-mousePD-1 (CD279), 50 mg and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0488579
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $4,725
About this award
Bio X Cell was awarded a purchase order (A207_PO-0488579) by the University of Virginia on October 6, 2026, for the delivery of specialized monoclonal antibodies. The cumulative contract value is $4,725.00. The supplies are designated for delivery to Timothy D Martin and consist of two distinct line items: InVivoMAb anti-mouse programmed death receptor 1 (CD279) in a 50-milligram formulation priced at $2,424.80, and InVivoMAb rat immunoglobulin G2a isotype control, anti-trinitrophenol, in a 50-milligram formulation priced at $2,300.20.
These monoclonal antibody products are commonly utilized in laboratory and research settings for immunological studies and in vivo research applications. The University of Virginia's procurement of these reagents through Bio X Cell indicates their use in research initiatives conducted within Virginia. No specific performance period beyond the award date of October 6, 2026, is documented in the contract award information provided.
Line items
| Item | Total |
|---|---|
| InVivoMAb anti-mousePD-1 (CD279), 50 mg | $2,424.80 |
| InVivoMAb rat IgG2aisotype control, anti-trinitrophenol, 50 mg | $2,300.20 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0488579?
Contract A207_PO-0488579 was awarded to Bio X Cell by University of Virginia on October 6, 2026.
How much is contract A207_PO-0488579 worth?
Its cumulative value is $4,725.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award